Fudan University
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 1905-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.fudan.edu.cn
Study of Personalized Tumour Vaccines and a PD-L1 Blocker in Patients With Surgically Resected Pancreatic Adenocarcino
Early Phase 1
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-12-05
- Last Posted Date
- 2023-12-05
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 30
- Registration Number
- NCT06156267
- Locations
- 🇨🇳
Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University, Shanghai, Shanghai, China
A Perioperative Sintilimab and Chemotherapy in Esophageal Squamous Cell Carcinoma
Phase 2
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-12-01
- Last Posted Date
- 2023-12-01
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 182
- Registration Number
- NCT06152978
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
Assessment of Early Pancreatic Cancer Prognosis by Minimal Residual Disease Using Multi-omics Approach
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-11-30
- Last Posted Date
- 2023-11-30
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 51
- Registration Number
- NCT06151691
- Locations
- 🇨🇳
Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University; 270 Dong An Road, Shanghai 200032, China, Shanghai, China
mFOLFIRINOX Plus Radiotherapy to Patients With CA19-9-normal Advanced Pancreatic Cancer
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-11-29
- Last Posted Date
- 2024-06-06
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 30
- Registration Number
- NCT06149689
- Locations
- 🇨🇳
Shanghai Cancer Center, Shanghai, China
Effect of ESPB on Postoperative Pain in Patients With Breast Cancer Implant Reconstruction
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2023-11-22
- Last Posted Date
- 2024-03-06
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 100
- Registration Number
- NCT06143020
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
IASLC Grading System as a Predictor for EGFR-TKI Therapy
Completed
- Conditions
- First Posted Date
- 2023-11-14
- Last Posted Date
- 2023-12-13
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 2160
- Registration Number
- NCT06131645
- Locations
- 🇨🇳
Chaoqiang Deng, Shanghai, Please Select, China
Radiotherapy + Chemoimmunotherapy Followed by Surgery in Patients With Limited Metastatic Gastric or GEJ Cancer
Phase 2
Recruiting
- Conditions
- Interventions
- Radiation: Radiotherapy targeted to the primary lesionRadiation: Radiotherapy targeted to the metastatic lesionsBiological: Anti-PD-1 monoclonal antibodyBiological: TrastuzumabDrug: ChemotherapyProcedure: R0 total/subtotal gastrectomy with D2 lymphadenectomyProcedure: MetastasectomyProcedure: Local ablative therapies
- First Posted Date
- 2023-11-08
- Last Posted Date
- 2023-11-08
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 55
- Registration Number
- NCT06121700
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, China
Postoperative Chemotherapy With/Without Radiotherapy and Immunotherapy for Colorectal Liver Metastases With High Risk of Locally Recurrence
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-11-07
- Last Posted Date
- 2023-11-07
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 80
- Registration Number
- NCT06120127
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
A Study of Surufatinib in the Treatment of Advanced Soft Tissue Sarcoma
- First Posted Date
- 2023-10-31
- Last Posted Date
- 2023-10-31
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 29
- Registration Number
- NCT06110650
Wedge Resection for Ground-glass Opacity-featured Lung Cancer (ECTOP-1020)
Phase 3
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-10-26
- Last Posted Date
- 2023-10-26
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 286
- Registration Number
- NCT06102161
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, China
© Copyright 2024. All Rights Reserved by MedPath